Closing soon

Cytopathology and Next Generation Sequencing Testing (Request for Quotes) Northport

Description: Provide cytopathology and next generation sequencing testing. Provide comprehensive, clinically validated molecular diagnostic testing using NGS to improve the evaluation and management of thyroid nodules with indeterminate FNA cytology, enhancing diagnostic accuracy, reducing unnecessary surgeries, and guiding timely intervention for patients at risk. See attached file.

Released
Aug 4, 2026
Closes
Aug 21, 2026(8 days left)

Files

Original attachments and procurement documents tied to this bid.

See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts